Rabies Diagnostics Market Demand Overview, Global Analysis, Advanced Share, Key Company Profiles and Industry Forecast to 2023
Market Overview:
The global rabies diagnostics market is
accounted for USD 1,964 million in
2017 and expected to register 4.36% CAGR during the forecast period (2018–2023).
Rabies is a
vaccine-preventable viral disease that occurs around 150 countries and
territories. It is a viral disease that transmitted through a bite from an infected
animal. Rabies is most common in the countries where the population of street
dogs is present in large numbers, especially in Asia and Africa. The factors propelling the growth of
the global rabies diagnostics market are raising awareness related to rabies, the prevalence of
rabies, and several animals. Moreover, increasing research and development
activities by non-profit organizations and aggressive strategies by top players
such as mergers, expansion, and collaboration for the development of new
products and launches by major players are also boosting the growth of the market.
However, high costs with the
diagnostic and rising vaccination may hamper the growth of the market during
the assessment period.
Browse Full Report Details and Full TOC Exclusively @ https://www.marketresearchfuture.com/reports/rabies-diagnostics-market-7796
Competitive
Landscape:
·
Bio-Rad Laboratories
·
Merck KGaA
·
Aviva Systems Biology Corporation
·
Creative Diagnostics
·
Demeditec Diagnostics GmbH
·
Abbexa Ltd
·
Norgen Biotek Corp.
·
BioNote
·
Express Biotech International Inc
·
MyBioSource.com
·
BioGen Technologies.
Segmentation:
·
The Global Rabies Diagnostics Market has been segmented on the basis of
method, technology, end-user, and region.
·
Based on method, the market has been classified as a fluorescent
antibody test (FAT), immunohistochemical test, amplification methods,
histologic examination, and serology tests.
·
Global rabies diagnostics market on the basis of technology has
been segmented into ELISA/immunohistochemistry, chromatography techniques, PCR,
and others.
·
Based on market has been segmented into hospitals, diagnostic
centers, cancer palliative care clinics, and others.
Regional
Analysis:
The market is likely to dominate by Asia-Pacific during the
forecast period owing to the improving
healthcare infrastructure, increasing investments in the healthcare sector and
expansions by market players in the region. Also, a country such as India and
China are considering the fastest growing region due to a government focused
toward adopting new technology, and the best treatment option from a developed
country.
The Americas are
expected to be the second-largest market in the global rabies diagnostics
market due to the rising collaborative activities by major players, raising
awareness about rabies, the involvement of non-profit organization to control
rabies, and well-established healthcare infrastructure.
The Asia-Pacific
market is likely to hold the majority share of the rabies diagnostics market owing to the improving
healthcare infrastructure, rising investments in healthcare, increasing
prevalence of rabies, raising awareness related to rabies, and an increasing
number of pet animals. According to a report published by the World
Health Organization, in September 2018, every year around 10,000 deaths occur owing
to rabies, mainly in Asia and Africa.
About Market Research Future:
At Market Research Future (MRFR), we enable our
customers to unravel the complexity of various industries through our Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Comments
Post a Comment